Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $852 | $213 | $0 | $0 | $0 | $345.7K | $2.7M |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $2.0M | $5.4M |
| Gross profit | $0 | $852 | $213 | $0 | $0 | $0 | −$1.7M | −$2.7M |
| Gross margin | — | 100.0% | 100.0% | — | — | — | -491.8% | -100.0% |
| R&D | $0 | $58.3K | $77.3K | $369.3K | $356.1K | $300.0K | $22.1K | $0 |
| Operating income | −$110.0K | −$420.3K | −$368.4K | −$1.6M | −$2.1M | −$2.4M | −$10.9M | −$10.6M |
| EBITDA | −$20.0K | −$294.8K | −$356.4K | −$1.6M | −$3.8M | −$3.9M | −$8.9M | −$9.9M |
| Net income | −$20.0K | −$296.6K | −$358.0K | −$1.6M | −$3.9M | −$4.3M | −$9.7M | −$10.9M |
| Net margin | — | -34808.8% | -168064.3% | — | — | — | -2802.3% | -402.2% |
| EPS (diluted) | -0.33 | -4.60 | -5.59 | -0.67 | -0.91 | -0.91 | -0.29 | -0.22 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds EXDI.
No tracked institution reports a position in EXDI as of their last filing.
| Execution date | Ratio |
|---|---|
| 2021-10-28 | 1-for-28reverse |
| 2019-03-11 | 1-for-8reverse |
No one on the platform has traded EXDI yet.
| $6M |
| — |
| FLWPFThe Flowr Corporation | $0.00 | +0.00% | $4265 | — |
| IMUNImmune Therapeutics, Inc. | $0.09 | -7.00% | $8M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.